Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BMS-820836 in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 01 Feb 2015
At a glance
- Drugs Liafensine (Primary)
- Indications Depressive disorders
- Focus Adverse reactions
- 10 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 10 Nov 2010 Planned end date changed from 1 Sep 2010 to 1 Nov 2010 as reported by ClinicalTrials.gov..
- 02 Apr 2010 Planned end date changed from 1 Mar 2010 to 1 Sep 2010 as reported by ClinicalTrials.gov.